(Q27495953)

Europe PubMed Central

13 March 2019

Europe PubMed Central

17 June 2019

Europe PubMed Central

on focus list of Wikimedia project

19 June 2019

copyright status

copyrighted

0 references

ScienceSource

0 references

cites work

Antihypertensive drug therapy for mild to moderate hypertension during pregnancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Mapping the theories of preeclampsia and the role of angiogenic factors: a systematic review

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Nitroprusside in preeclampsia. Circulatory distress and paradoxical bradycardia

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Hypertension produced by placental ischemia in pregnant rats is associated with increased soluble endoglin expression

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

The role of angiogenic factors in the prediction and diagnosis of preeclampsia superimposed on chronic hypertension

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Clinical practice. Chronic hypertension in pregnancy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Preeclampsia and the Anti-Angiogenic State

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Angiogenic factors and preeclampsia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Emerging role of relaxin in the maternal adaptations to normal pregnancy: implications for preeclampsia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

First trimester uric acid and adverse pregnancy outcomes

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Angiotensin receptor agonistic autoantibody is highly prevalent in preeclampsia: correlation with disease severity

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Potential markers of preeclampsia--a review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Accuracy of serum uric acid as a predictive test for maternal complications in pre-eclampsia: bivariate meta-analysis and decision analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Prediction and prevention of recurrent preeclampsia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Accuracy of mean arterial pressure and blood pressure measurements in predicting pre-eclampsia: systematic review and meta-analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Update on the use of antihypertensive drugs in pregnancy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Circulatory soluble endoglin and its predictive value for preeclampsia in second-trimester pregnancies with abnormal uterine perfusion

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Genes and the preeclampsia syndrome

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Major congenital malformations after first-trimester exposure to ACE inhibitors

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Accuracy of serum uric acid determination in predicting pre-eclampsia: a systematic review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Accuracy of serum uric acid in predicting complications of pre-eclampsia: a systematic review.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Manifestations of chronic disease during pregnancy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Insulin resistance and sympathetic overactivity in women

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Use of protein:creatinine ratio measurements on random urine samples for prediction of significant proteinuria: a systematic review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

The renal response to preeclampsia

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Postpartum hypertension and nonsteroidal analgesia.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Hydralazine for treatment of severe hypertension in pregnancy: meta-analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Magnesium sulfate in women with mild preeclampsia: a randomized controlled trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Pre-eclampsia in pregnancy and subsequent risk for breast cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Drugs in pregnancy. Antihypertensives

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Transfer of drugs and other chemicals into human milk

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Pharmacological treatment of severe hypertension in pregnancy and the role of serotonin(2)-receptor blockers

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Serotonin antagonism and serotonin antagonists in pregnancy: role of ketanserin

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

How useful is uterine artery Doppler flow velocimetry in the prediction of pre-eclampsia, intrauterine growth retardation and perinatal death? An overview

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Fetal and maternal contributions to risk of pre-eclampsia: population based study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Report of the Canadian Hypertension Society Consensus Conference: 3. Pharmacologic treatment of hypertensive disorders in pregnancy.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

First year of life after the use of atenolol in pregnancy associated hypertension

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Management of hypertension during lactation

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

A study of angiotensin II pressor response throughout primigravid pregnancy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Overview of randomised trials of diuretics in pregnancy.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Kidney function in pregnant women

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Atenolol in essential hypertension during pregnancy

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Eclampsia. VII. Pregnancy outcome after eclampsia and long-term prognosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Treatment of hypertension in pregnancy with methyldopa: blood pressure control and side effects

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for Preeclampsia Prevention Study Group

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Endothelial dysfunction in preeclampsia

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

An overview of the influence of ACE inhibitors on fetal-placental circulation and perinatal development

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Severe hypotension and fetal distress following sublingual administration of nifedipine to a patient with severe pregnancy induced hypertension at 33 weeks

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Chronic decrease of blood pressure by rat relaxin in spontaneously hypertensive rats

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Is clonidine a behavioural teratogen in the human?

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

The effect of sublingual nifedipine on uteroplacental blood flow in hypertensive pregnancy

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Preeclampsia: an endothelial cell disorder

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Prediction of pregnancy-induced hypertensive disorders by angiotensin II sensitivity and supine pressor test.

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Circulating angiogenic factors and the risk of preeclampsia

2 June 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F105918

Uteroplacental ischemia results in proteinuric hypertension and elevated sFLT-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F105918

Relaxin is essential for systemic vasodilation and increased global arterial compliance during early pregnancy in conscious rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F105918

Preeclampsia and risk of developing subsequent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F105918

Allelic variations in angiogenic pathway genes are associated with preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F105918

Paternal and maternal components of the predisposition to preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F105918

Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F105918

Financial impact of a novel pre-eclampsia diagnostic test versus standard practice: a decision-analytic modeling analysis from a UK healthcare payer perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F105918

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F105918

Soluble endoglin as a second-trimester marker for preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F105918

Effective prediction of preeclampsia by a combined ratio of angiogenesis-related factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F105918

Pilot study of extracorporeal removal of soluble fms-like tyrosine kinase 1 in preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F105918

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F105918

Hypertension during pregnancy in South Australia, part 1: pregnancy outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F105918

Impaired vascular dilatation in women with a history of pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F105918

Association of maternal endothelial dysfunction with preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F105918

Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F105918

Preeclampsia and the risk of end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F105918

Preeclampsia and subsequent risk of cancer in Utah

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F105918

Placental characteristics and reduced risk of maternal breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F105918

Mild gestational hypertension remote from term: progression and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F105918

Effect of atenolol on birth weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F105918

Efficacy and safety of nifedipine tablets for the acute treatment of severe hypertension in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F105918

The effect of isosorbide dinitrate, a donor of nitric oxide, on maternal cerebral blood flow in gestational hypertension and preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F105918

Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F105918

A sister's risk: Family history as a predictor of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F105918

Predicting Transformation from Gestational Hypertension to Preeclampsia in Clinical Practice: A Possible Role for 24 Hour Ambulatory Blood Pressure Monitoring

21 January 2018

1 reference

https://api.crossref.org/works/10.1155%2F2012%2F105918

Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia

21 January 2018

2 references

https://api.crossref.org/works/10.1155%2F2012%2F105918

21 January 2018

12 December 2020

Use of a random urinary protein-to-creatinine ratio for the diagnosis of significant proteinuria during pregnancy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3366228

Nifedipine transfer into human milk

27 November 2018

1 reference

12 December 2020

Spironolactone therapy during human pregnancy

1 reference

12 December 2020

Hydralazine-induced neonatal thrombocytopenia

1 reference

12 December 2020

Diagnosis, Evaluation, and Management of the Hypertensive Disorders of Pregnancy

1 reference

12 December 2020

Is the urine spot protein/creatinine ratio a valid diagnostic test for pre-eclampsia?

1 reference

12 December 2020

Structural and functional changes in left ventricle during normotensive and preeclamptic pregnancy

1 reference

12 December 2020

Clonidine hydrochloride--a safe and effective antihypertensive agent in pregnancy

1 reference

12 December 2020

Pressor response to angiotonin in pregnant and nonpregnant women

1 reference

12 December 2020

The safety of calcium channel blockers in human pregnancy: a prospective, multicenter cohort study

1 reference

12 December 2020

Hypocalciuria in preeclampsia

1 reference

12 December 2020

A clinical test useful for predicting the development of acute hypertension in pregnancy

1 reference

12 December 2020

Phaeochromocytoma in pregnancy

1 reference

12 December 2020

Pheochromocytoma: antepartum diagnosis and management with tumor resection in the puerperium

1 reference

12 December 2020

Concentrations of beta-blocking drugs in human milk

1 reference

12 December 2020

The fetal outcome in a randomized double-blind controlled trial of labetalol versus placebo in pregnancy-induced hypertension

1 reference

12 December 2020

Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study

1 reference

12 December 2020

Relaxin modifies systemic arterial resistance and compliance in conscious, nonpregnant rats

1 reference

12 December 2020

Recurrence risk of preeclampsia in twin and singleton pregnancies

1 reference

12 December 2020

Soluble Endoglin for the Prediction of Preeclampsia in a High Risk Cohort

1 reference

12 December 2020

Angiotensin-converting enzyme inhibitor fetopathy

1 reference

12 December 2020

Random protein-creatinine ratio for the quantitation of proteinuria in pregnancy

1 reference

12 December 2020

A comparison of labetalol plus hospitalization versus hospitalization alone in the management of preeclampsia remote from term

1 reference

12 December 2020

Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia

1 reference

12 December 2020

Novel splice variants of sFlt1 are upregulated in preeclampsia

1 reference

12 December 2020

Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis

1 reference

12 December 2020

Vascular reactivity and electrolytes in normal and toxemic pregnancy; pathogenic considerations and a diagnostic pre-toxemia test

1 reference

12 December 2020

Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy

1 reference

12 December 2020

Effects of nifedipine on umbilical artery velocity waveforms in healthy human fetuses

1 reference

12 December 2020

Recurrence of preeclampsia: effects of gestational age at delivery of the first pregnancy, body mass index, paternity, and interval between births

1 reference

12 December 2020

Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion

1 reference

12 December 2020

Pre-eclampsia in second pregnancy

1 reference

12 December 2020

The effect of nifedipine on fetal umbilical artery Doppler waveforms in pregnancies complicated by hypertension

1 reference

12 December 2020

Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia

1 reference

12 December 2020

Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop

1 reference

12 December 2020

Chronic hypertension in pregnancy

1 reference

12 December 2020

Long-term Impact of Reproductive Factors on the Risk of Cervical, Endometrial, Ovarian and Breast Cancer

1 reference

12 December 2020

The management of postpartum hypertension

1 reference

12 December 2020

Pre-eclampsia and trisomy 13

1 reference

12 December 2020

Effects of methyldopa on uteroplacental and fetal hemodynamics in pregnancy-induced hypertension

1 reference

12 December 2020

release_ou7iwg64yrc67ecvlx6zlj6j5a

Identifiers

DOI

10.1155/2012/105918

0 references

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ou7iwg64yrc67ecvlx6zlj6j5a

24 November 2022